Rain Therapeutics Inc., a privately-held, clinical stage biotechnology company, has appointed Rain co-founder Robert Doebele, MD, PhD, as chief scientific officer (CSO).   Doebele has served as chair of the scientific advisory board and acting CSO since Rain’s founding. He will now transition to Rain full-time in the executive vice president (EVP) and CSO role, departing his position at the University of Colorado, Denver as associate professor of medicine. In his new role, Doebele will be respon...